Speaker
NEOGAP Therapeutics AB
Anne-Laure Joly, NEOGAP Therapeutics AB, is speaking at 8th TIL Therapies Summit 2026 (Boston, United States of America, 17–19 Nov 2026) in the session “Balancing Process Flexibility & Standardization While Preserving Antigen Specificity”.
17–19 Nov 2026Boston, United States of America
CuraCell Holding AB
CTMC
Texas Tech University Health Sciences Center
Hongzhou Huasai Biomedicine
University of Colorado
Stanford University
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Anne-Laure Joly, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].